![Stephen Glover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Glover
Chief Executive Officer at
ZYVERSA THERAPEUTICS, INC.
Net worth: 85 532 $ as of 30/05/2026
Profile
Stephen C.
Glover is the founder of ZyVersa Therapeutics Operating, Inc., founded in 2014, where the title held is Chairman & Chief Executive Officer.
Mr. Glover was the founder of Coherus Oncology, Inc., founded in 2010, where the title held was Chief Business Officer from 2010 to 2013.
Mr. Glover is the founder of ZyVersa Therapeutics, Inc., founded in 2014, where the title held is Chairman, President & Chief Executive Officer since 2022.
Current jobs include Chairman at PDS Biotechnology Corp.
since 2019; Director at Wallace H.
Coulter Foundation, Biogene Therapeutics, Inc., Asclepius Life Sciences Fund LP, Inflamacore LLC, and Two B Pharma; and Director at Oncolytics Biotech, Inc. starting in 2026.
Former jobs include Chairman at Ambrx Biopharma Cayman, Inc. from 2023 to 2024; Chairman at Ambrx, Inc.; Director at INCON Co., Ltd. and Auriga Laboratories, Inc.; Senior Vice President-Brand Operations at Andrx Corp.
from 2003 to 2006; President at Insmed Therapeutic Proteins from 2007 to 2009; Chief Business Officer & Executive Vice President at Insmed, Inc. from 2007 to 2010; Senior Vice President & General Manager at Andrx Laboratories, Inc.; and Senior Vice President & General Manager at Watson Therapeutics, Inc. Education includes undergraduate studies at Illinois State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/01/2026 | 78,851 ( 0.14% ) | 85 159 $ | 30/05/2026 | |
| 10/07/2025 | 1,819 ( 0.02% ) | 373 $ | 30/05/2026 | |
| 31/05/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Stephen Glover active positions
| Companies | Position | Start |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chairman | - |
| ZYVERSA THERAPEUTICS, INC. | Chief Executive Officer | 30/11/2022 |
| ONCOLYTICS BIOTECH INC. | Director/Board Member | 31/05/2026 |
Inflamacore LLC | Director/Board Member | - |
Wallace H. Coulter Foundation
 Wallace H. Coulter Foundation Miscellaneous Commercial ServicesCommercial Services Foundation | Director/Board Member | - |
Two B Pharma
 Two B Pharma Pharmaceuticals: GenericHealth Technology Operates as a clinical-stage pharmaceutical company which develops drugs | Director/Board Member | - |
Asclepius Life Sciences Fund LP
 Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Provides pooled investment funds | Director/Board Member | - |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Chief Executive Officer | 28/02/2014 |
Former positions of Stephen Glover
| Companies | Position | End |
|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Chairman | 06/03/2024 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Stephen Glover
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Andrx Corp.
 Andrx Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral pharmaceuticals products | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Wallace H. Coulter Foundation
Wallace H. Coulter Foundation Miscellaneous Commercial ServicesCommercial Services Foundation | Commercial Services |
Illinois State University
 Illinois State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
INCON Co., Ltd.
 INCON Co., Ltd. Electronics/AppliancesConsumer Durables Manufactures and sells digital video recorders | Consumer Durables |
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Health Technology |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactured specialty pharmaceuticals | Health Technology |
Insmed Therapeutic Proteins | |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Watson Therapeutics, Inc. | |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
Asclepius Life Sciences Fund LP
Asclepius Life Sciences Fund LP Financial ConglomeratesFinance Provides pooled investment funds | Finance |
Inflamacore LLC | |
Two B Pharma
Two B Pharma Pharmaceuticals: GenericHealth Technology Operates as a clinical-stage pharmaceutical company which develops drugs | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Stephen Glover
